
News|Articles|January 10, 2005
New Product Newswire
Reliant Pharmaceutical, Liberty Corner, N.J., (908) 580-1200, has gained approval for a new lipid-lowering agent. Antara (fenofibrate) Capsules are indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and ApoB and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Retatrutide Delivers Weight Loss, A1C Improvements in Additional Trials
2
Pharmacies Successfully Scale Paid SDOH Services Through Medicaid
3
FDA Approves Furoscix ReadyFlow, First Autoinjector for IV Furosemide
4
FDA Votes in Favor of Peptides After Lengthy Deliberation
5

























